在瘤学中推进表观遗传组合疗法:多功能纳米药物输送系统,以实现协同效率和精确调制
Tong Gao1, Shunli Fu2, Xianghua Quan1
1Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao, 266000, People's Republic of China.
本综述探讨了纳米药物输送系统 (NDDS) 如何改善癌症的表观遗传组合疗法. 多功能NDDS提供了对药物输送的精确控制,提高了治疗效率,为个性化癌症护理铺平了道路.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 表观遗传修饰对于癌症的发展和进展至关重要.
- 表观遗传组合疗法显示出希望,但面临着药物药理动力学和生物分布的挑战.
- 纳米药物递送系统 (NDDS) 提供了联合递送和药物动力学优化的潜力.
研究的目的:
- 审查癌症表观遗传失调的机制.
- 分析当前的表观遗传组合疗法及其局限性.
- 突出多功能NDDS在推进精确癌症治疗的表观遗传组合疗法的作用.
主要方法:
- 对表观遗传失调机制的文献综述.
- 对瘤学中现有的表观遗传组合策略的分析.
- 探索NDDS设计原则的联合交付和药物动力学调制.
- 讨论用于精确治疗调节的多功能NDDS.
主要成果:
- 表观遗传失调驱动瘤发生,使表观遗传疗法成为一个关键的重点.
- 在组合疗法中,NDDS可以克服药理动力学和生物分布方面的挑战.
- 多功能NDDS能够精确控制治疗剂的输送,以改善癌症治疗.
结论:
- 创新的NDDS设计对于表观遗传组合疗法的临床转化至关重要.
- 多功能NDDS具有个性化癌症治疗的巨大潜力.
- 在人工智能驱动的NDDS,仿生载体和表观遗传编辑方面的未来进展将进一步个性化癌症治疗.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Treatment Resistant Cancers
